Controlled oral glucose tolerance test: Evaluation of insulin resistance with an insulin infusion algorithm that forces the OGTT glycaemic curve within the normal range. A feasibility study

Clinical Physiology

Volumn 19, Issue 1, 1999, Pages 32-44

  Volpicelli, G ^a   Iannello, S ^a   Belfiore, F ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

Author keywords

Algorithm; Diabetes; Free fatty acids; Insulin infusion; Insulin resistance; Insulin secretion; Non esterified fatty acids; Obesity; Oral glucose tolerance test

Indexed keywords

C PEPTIDE; FATTY ACID; INSULIN; MONOCOMPONENT INSULIN;

ADULT; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC OBESITY; FATTY ACID BLOOD LEVEL; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN INFUSION; INSULIN RELEASE; INSULIN RESISTANCE; NEGATIVE FEEDBACK; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADULT; ALGORITHMS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, COMPUTER-ASSISTED; FEASIBILITY STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; OBESITY; REFERENCE VALUES;

EID: 21544441477     PISSN: 01445979     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2281.1999.00144.x     Document Type: Article

References (46)

1. AKANJI A. O., BRUCE M., FRAYN K., HOCKADAY T. D. R. & KADDAHA G. M. (1987) Oral glucose tolerance and ambient temperature in non-diabetic subjects. Diabetologia, 30, 431-433.
2. ALFORD F. P., MARTIN F. I. R. & PEARSON M. J. (1971) The significance and interpretation of mildly abnormal oral glucose tolerance. Diabetologia, 7, 173-180.
3. ANDRES R., SWERDLOFF R., POZEFSKY T. & COLEMAN D. (1966) Manual feedback technique for the control of blood glucose concentration. In. Automation in Analytical Chemistry (ed. SKEGGS L. T. JR), pp. 486-491. Mediad, New York.
4. BERGMAN R. N. (1989) Toward physiological understanding of glucose tolerance: minimal-model approach (Lilly Lecture). Diabetes, 38, 1512-1527.
5. BERGMAN R. N., IDER Y. Z., BOW-DEN C. R. & COBELLI C. (1979) Quantitative estimation of insulin sensitivity. Am J Physiol, 236, E667-E677.
6. BERGMAN R. N., PHILLIPS S. L. & COBELLI C. (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest, 68, 1456-1467.
7. BONADONNA R. C., ZYCH K., BONI C., FERRANNINI E. & DEFRONZO R. A. (1989) Time dependence of the interaction between lipids and glucose in humans. Am J Physiol, 257, E49-E56.
8. BONORA E., MOGHETTI P., ZANCANARO C., et al. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab, 68, 374-378.
9. BROEKHUYSE H. M., NELSON J. D., ZINMAN B. & ALBISSER A. M. (1981) Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cell. IEEE Trans Biomed Eng, 28, 678-687.
10. CERASI E., LUFT R. & EFENDIC S. (1972) Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects: a glucose dose-response study. Diabetes, 21, 224-234.
11. COBELLI C., PACINI G. & SALVAN A. (1980) On a simple model of insulin secretion. Med Biol Eng Comput, 18, 457-463.
12. COBELLI C., FEDERSPIL G., PACINI G., SALVAN A. & SCANDELLARI C. (1982) An integrated mathematical model of the dynamics of blood glucose and its hormonal controllers. Math Biosci, 58, 27-60.
13. DE FRONZO R. A., TOBIN J. & ANDRES R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol, 237, E214-E273.
14. DE FRONZO R. A. (1988) The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM (Lilly Lecture). Diabetes, 37, 667-687.
15. FERRANNINI E., BARRET E. J., BEVILACQUA S. & DEFRONZO R. A. (1983) Effect of fatty acids on glucose production and utilization in man. J Clin Invest, 72, 1737-1747.
16. FISHER U., DETSCHEW W., JUTZI E., et al. (1985) In vivo comparison of different algorithms for the artificial beta cell, Int J Artif Organs, 9, 173-179.
17. FREEMAN H., LOONEY J. M. & HOSKINS R. G. (1942) Spontaneous variability of oral glucose tolerance. J Clin Endocrinol, 2, 431-434.
18. GANDA O. P., DAY J. L., SOELDNER J. S., CONNON J. J. & GLEASON R. E. (1978). Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes, 27, 715-725.
19. GLANTZ S. A. (1988) Primer of Biostatistics McGraw-Hill, New York.
20. GROOP L. C., BONADONNA R. C., SHANK M., PETRIDES A. S. & DEFRONZO R. A. (1991) Role of free fatty acids and insulin in determining free fatty acids and lipid oxidation in man. J Clin Invest, 87, 83-89.
21. HALES C. N. & RANDLE P. J. (1963) Immunoassay of insulin with insulin-antibody precipitate. Lancet, 1, 200.
22. HARANO Y., OHGAKU S., HIDAKA H., et al. (1977) Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab, 45, 1124-1127.
23. HARDING P. E., OAKLEY N. W. & WYNN V. (1973) Reproducibility of oral glucose tolerance data in normal and mildly diabetic subjects. Clin Endocrinol, 2, 387-395.
24. HARRIS P. E., KITANGE H. M., FULCHER G. & ALBERTI K. G. M. M. (1991) The oral glucose tolerance test: effects of different glucose loads, reproducibility and the timing of blood glucose measurements. Diab Nutr Metab, 4, 293-296.
25. HOSKER J. P., MATTHEWS D. R., RUDENSKI A. S., et al. (1985) Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia, 28, 401-411.
26. INSEL P. A., LILJENQUIST J. E. & TOBIN. J. D. (1975) Insulin control of glucose metabolism in man. A new kinetic approach. J Clin Invest, 55, 1057-1066.
27. KANEKO T., OKA H., MUNEMURA M., ODA T. & YAMASHITA K. (1974) Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide. Endocrinol Japan, 21, 141-145.
28. LUZI L. & DEFRONZO R. A. (1989) Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol, 257, E241-E246.
29. MCDONALD G. W., FISHER G. F. & BURNHAM C. (1965) Reproducibility of the oral glucose tolerance test. Diabetes, 14, 473-480.
30. NATIONAL DIABETES DATA GROUP (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039-1057.
31. NUUTILA P., KOIVISTO V. A., KNUUTI J., et al. (1992). Glucose-free fatty acids cycle operates in human heart and skeletal muscle in vivo. J Clin Invest, 89, 1767-1774.
32. OLEFSKY J. M. & REAVEN G. M. (1974) Insulin and glucose responses to identical oral glucose tolerance tests performed fortyeight hours apart. Diabetes, 23, 449-453.
33. PFEIFFER E. F., THUM C. & CLEMENS A. H. (1974) The artificial beta cell: a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res, 6, 339-342.
34. PIATTI P. M., MONTI C. D., PACCHIONI M., PONTIROLI A. E. & POZZA G. (1991) Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism, 40, 926-933.
35. PORRO G. P., MIRACOLI L., PALAZZO P., FONTANA E., BERNARDI L. & FONTANA I. (1986) Technical development and clinical evaluation of a new desktop artificial pancreas utilizing extracorporeal hemofiltration. In: Progress in Artificial Organs 1985 (eds NOSÈ Y. KJELLESTRAND C. & VANOVICH P.), pp. 682-686. ISAO Press, Cleveland.
36. RANDLE P. J., GARLAND P. B., HALES C. N. & NEWSHOLME E. A. (1963) The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1, 785-789.
37. RANDLE P. J., PRIESTMAN D. A., MISTRY S. & HALSALL A. (1994) Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia, 37 (Suppl. 2), S155-S161.
38. RATZMAN K. P., BESCH W., WITT S. & SCHULZ B. (1981) Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance. Diabetologia, 21, 192-197.
39. REBOLDI G. P., HOME P. D., CALABRESE G., FABIETTI P. G., BRUNETTI P. & MASSI BENEDETTI M. (1991) Design and simulation of a time delay compensator for closed-loop insulin delivery, Int J Artif Organs, 14, 350-358.
40. RICCARDI G., VACCARO O., RIVELLESE A., PIGNALOSA S., TUTINO L. & MANCINI M. (1985) Reproducibility of the new diagnostic criteria for impaired glucose tolerance. Am J Epidemiol, 121, 422-429.
41. RIZZA R. A., GERICH J. E., HAYMOND M. W., et al. (1980) Control of blood sugar in insulin dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion and intensified conventional therapy. N Engl J Med, 303, 1313-1318.
42. SELTZER H. S. (1970) Diagnosis of diabetes. In: Diabetes Mellitus: Theory and Practice (eds ELLENBERG M. & RIFKIN H.), pp. 436-507. McGraw-Hill, New York.
43. SHEN S. W., REAVEN G. M. & FARQUHAR J. W. (1970) Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest, 49, 2151-2160.
44. SHERWIN R. S., KRAMER K. J., TOBIN J. D., et al. (1974) A model of the kinetics of insulin in man. J Clin Invest, 53, 1481-1492.
45. THIEBAUD D., JACOT E., DEFRONZO R., MAEDER E., JEQUIER E. & FELBER J. P. (1982) The effect of graded doses of insulin on total glucose uptake, glucose oxidation and glucose storage in man. Diabetes, 31, 957-963.
46. WALKER M., FULCHER G. R., SUM C. F., ORSKOV H. & ALBERTI K. G. M. M. (1991) Effects of glycemia and nonesterified fatty acids on forearm glucose uptake in normal humans. Am J Physiol, 261, E304-E311.